Drug registration in China involves several fees, including application fees, technical review fees, and inspection fees. These cover the costs of dossier evaluation, clinical trial assessments, and Good Manufacturing Practice (GMP) inspections. Fees vary based on drug type, such as new drugs, generics, or biologics, and the complexity of the review process.